Long‐term follow‐up of chronic central serous chorioretinopathy patients receiving oral eplerenone and half‐dose photodynamic therapy in the SPECTRA trial: SPECTRA trial report No. 4
- DOI
- 10.1111/aos.70106
- Published
- 2026-02-11
- Container
- Acta Ophthalmologica
- Publisher
- Wiley
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1111/aos.70106,
title = {Long‐term follow‐up of chronic central serous chorioretinopathy patients receiving oral eplerenone and half‐dose photodynamic therapy in the SPECTRA trial: SPECTRA trial report No. 4},
author = {Helena M. A. Feenstra and Issam El Mansori and Thomas J. van Rijssen and Roula Tsonaka and Roselie M. H. Diederen and Carel B. Hoyng and Reinier O. Schlingemann and Camiel J. F. Boon and Elon H. C. van Dijk},
year = {2026},
journal = {Acta Ophthalmologica},
doi = {10.1111/aos.70106},
url = {https://doi.org/10.1111/aos.70106}
}RIS
TY - JOUR TI - Long‐term follow‐up of chronic central serous chorioretinopathy patients receiving oral eplerenone and half‐dose photodynamic therapy in the SPECTRA trial: SPECTRA trial report No. 4 AU - Helena M. A. Feenstra AU - Issam El Mansori AU - Thomas J. van Rijssen AU - Roula Tsonaka AU - Roselie M. H. Diederen AU - Carel B. Hoyng AU - Reinier O. Schlingemann AU - Camiel J. F. Boon AU - Elon H. C. van Dijk PY - 2026 JO - Acta Ophthalmologica DO - 10.1111/aos.70106 UR - https://doi.org/10.1111/aos.70106 ER -
APA
Feenstra, H. M. A., Mansori, I. E., Rijssen, T. J. V., Tsonaka, R., Diederen, R. M. H., Hoyng, C. B., Schlingemann, R. O., Boon, C. J. F., & Dijk, E. H. C. V. (2026). Long‐term follow‐up of chronic central serous chorioretinopathy patients receiving oral eplerenone and half‐dose photodynamic therapy in the SPECTRA trial: SPECTRA trial report No. 4. Acta Ophthalmologica. https://doi.org/10.1111/aos.70106
Source records
- crossref · retrieved 2026-09-25T05:18:00.138Z